FDA Drug Application (021866) for ABILIFY by OTSUKA

Back to FDA Applications sponsored by OTSUKA

Application Number021866
Product Number001
FormINJECTABLE;INTRAMUSCULAR
Dosage9.75MG/1.3ML (7.5MG/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABILIFY
Active IngredientARIPIPRAZOLE



Back to FDA Applications sponsored by OTSUKA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.